APA (7th ed.) Citation

M, D., K, Z., W, C., J, C., X, L., L, C., . . . A, L. (2026). Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD. CNS neuroscience & therapeutics, 32(6), e70973. https://doi.org/10.1002/cns.70973

Chicago Style (17th ed.) Citation

M, Deng, Zeng K, Chen W, Chen J, Lin X, Chen L, Yao Y, Chen H, and Lin A. "Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD." CNS Neuroscience & Therapeutics 32, no. 6 (2026): e70973. https://doi.org/10.1002/cns.70973.

MLA (9th ed.) Citation

M, Deng, et al. "Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD." CNS Neuroscience & Therapeutics, vol. 32, no. 6, 2026, p. e70973, https://doi.org/10.1002/cns.70973.